Quetiapine Fumarate
Product Images NDC 50090-5442

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 50090-5442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905442)

Label for QUETIAPINE FUMARATE 300 MG extended-release tablets by A-S Medication Solutions. The label includes product NDC 50090-5442-0 and states the package contains 60 tablets. It instructs to store at 68 to 77 degrees Fahrenheit and notes the dosage strength and form clearly.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Figure 1)

A line graph showing the proportion of patients with relapse (%) over time (months) for two groups: PLA (placebo) represented by a dashed line, and QTP XR (quetiapine extended-release) represented by a solid line. The graph tracks relapse rates over approximately 7 months, with the placebo group showing a higher proportion of relapse compared to the quetiapine group.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Figure 2)

A line graph depicting the proportion of patients with relapse (%) over time (weeks). Two groups are compared: QTP+ LI/VAL and PLA+ LI/VAL. The graph shows how relapse rates increase over approximately 90 weeks for both groups, with the PLA+ LI/VAL group having a higher proportion of patients with relapse throughout the period.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Figure 3)

A line graph showing the proportion of patients with relapse (%) over time (weeks). Two lines represent different treatment groups: one dashed line labeled QTP+ LI/VAL and one solid line labeled PLA+ LI/VAL, illustrating relapse rates over a 100-week period.*

FDA Label Image

Structural Formula (Quetiapine Structure)

Chemical structure diagram of the active ingredient quetiapine fumarate, showing the molecular arrangement of quetiapine and fumarate ions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.